Author pages are created from data sourced from our academic publisher partnerships and public sources.
- Publications
- Influence
Frontal lobe epilepsy: Clinical characteristics, surgical outcomes and diagnostic modalities
OBJECTIVE
To identify surgical prognostic factors and to characterize clinical features according to the location of the intracranial ictal onset zone of frontal lobe epilepsy (FLE) in order to… Expand
Treatment strategies for autoimmune encephalitis
- Yong-won Shin, S. Lee, +4 authors K. Chu
- Medicine
- Therapeutic advances in neurological disorders
- 16 August 2017
Autoimmune encephalitis is one of the most rapidly growing research topics in neurology. Along with discoveries of novel antibodies associated with the disease, clinical experience and outcomes with… Expand
Tocilizumab in Autoimmune Encephalitis Refractory to Rituximab: An Institutional Cohort Study
- Woo-Jin Lee, Soon-Tae Lee, +15 authors K. Chu
- Medicine
- Neurotherapeutics
- 23 May 2016
A considerable portion of autoimmune encephalitis (AE) does not respond to conventional immunotherapies and subsequently has poor outcomes. We aimed to determine the efficacy of tocilizumab, an… Expand
Neuropathologic and Clinical Features of Human Medial Temporal Lobe Epilepsy
- Eun-kee Bae, Keun-Hwa Jung, +7 authors J. Roh
- Psychology, Medicine
- Journal of clinical neurology
- 1 June 2010
Background and Purpose There is recent evidence of various types of morphological changes in the hippocampus of a rodent model of medial temporal lobe epilepsy (mTLE). However, little is known about… Expand
Prolonged–release melatonin in patients with idiopathic REM sleep behavior disorder
- Jin-Sun Jun, R. Kim, +10 authors K. Jung
- Medicine
- Annals of clinical and translational neurology
- 7 March 2019
We investigated the effects of prolonged‐release melatonin (PRM) on idiopathic rapid eye movement (REM) sleep behavior disorder (iRBD).
Anti‐LGI1 encephalitis is associated with unique HLA subtypes
Autoimmune encephalitis (AE), represented by anti–leucine‐rich glioma‐inactivated 1 (anti‐LGI1) and anti–N‐methyl‐D‐aspartate receptor (anti‐NMDAR) encephalitis, has increasing clinical significance… Expand
Anti-N-Methyl-D-Aspartate Receptor Encephalitis in Korea: Clinical Features, Treatment, and Outcome
- Jung-Ah Lim, S. Lee, +11 authors K. Chu
- Medicine
- Journal of clinical neurology
- 1 April 2014
Background and Purpose Anti-N-methyl-D-aspartate receptor (anti-NMDAR) encephalitis is the most common type of autoimmune synaptic encephalitis and it often responds to treatment. We analyzed the… Expand
Role of cortical dysplasia in epileptogenesis following prolonged febrile seizure
Purpose: Hippocampal sclerosis, characterized by prominent neuronal loss and reactive gliosis, is the most common pathology in human temporal lobe epilepsy (TLE). Although prolonged febrile… Expand
High albumin level is a predictor of favorable response to immunotherapy in autoimmune encephalitis
- Yoonhyuk Jang, S. Lee, +6 authors S. Lee
- Medicine
- Scientific Reports
- 17 January 2018
There is no known biomarker that predicts the response to immune therapy in autoimmune synaptic encephalitis. Thus, we investigated serum albumin as a prognostic biomarker of early immune therapies… Expand